Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04811014 · ClinicalTrials.gov registry record · Phase 4
Young Houston Emergency Opioid Engagement System
A Phase 4 study of Opioid Use Disorder and Opioid Use, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT04811014: Recruiting Phase 4 study of Opioid Use Disorder and Opioid Use, sponsored by The University of Texas Health Science Center, Houston.
NCT04811014 is a Phase 4 study of Opioid Use Disorder and Opioid Use that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 250 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04811014, a Phase 4 study of Opioid Use Disorder and Opioid Use, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The Houston Emergency Response Opioid Engagement System for Youths and Adolescents (Young HEROES) is a community-based research program integrating assertive outreach, medication for opioid use disorder (MOUD), behavioral counseling, and peer recovery support. The objective is to compare differences in engagement and retention in treatment for individuals with opioid use disorder. The investigators also intend to understand the prevalence of opioid overdoses and OUD among youth in Houston.
Primary Outcome
Percentage of enrolled youth in treatment over time
Conditions Studied
Interventions
- DRUG Buprenorphine, Naloxone Drug Combination
- BEHAVIORAL Individual Counseling
- BEHAVIORAL Peer Recovery Support Services
- BEHAVIORAL Support Group
- BEHAVIORAL Referral to Medication Management
Study Locations (1)
Texas
- The University of Texas Health Science Center at Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2021-04-19 |
| Est. Completion | 2030-08-31 |
| Phase | Phase 4 |
What NCT04811014 shows while recruiting
NCT04811014 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower).
The record links to 5 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 5 interventions - of which Buprenorphine, Naloxone Drug Combination is the first listed.
NCT04811014 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04811014 about?
NCT04811014 is a clinical study titled "Young Houston Emergency Opioid Engagement System". The Houston Emergency Response Opioid Engagement System for Youths and Adolescents (Young HEROES) is a community-based research program integrating assertive outreach, medication for opioid use disorder (MOUD), behavioral counseling, and peer recovery support. The objective is to compare differences...
What is the current status of trial NCT04811014?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2021-04-19. Estimated completion is 2030-08-31.
What conditions does trial NCT04811014 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Use, Substance Use Disorders, Opioid Dependence, Opioid Overdose.
What interventions are being tested in trial NCT04811014?
The interventions under investigation include: Buprenorphine, Naloxone Drug Combination (DRUG), Individual Counseling (BEHAVIORAL), Peer Recovery Support Services (BEHAVIORAL), Support Group (BEHAVIORAL), Referral to Medication Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT04811014?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04811014 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04811014's enrollment target sits among peer trials
250 70th of 257 higher than 185 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
RECRUITING · Phase 4
-
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
RECRUITING · Phase 4
-
Assessing Optimal XRB Initiation Points in Jail
RECRUITING · Phase 4
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
RECRUITING · Phase 4
-
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
RECRUITING · Phase 4
-
Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI